(Q43565621)

English

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial

scientific article published on 11 August 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1 reference

based on heuristic

inferred from title

author name string

T Burkard

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

C A Kaiser

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

H Brunner-La Rocca

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

S Osswald

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

M E Pfisterer

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

R V Jeger

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

BASKET Investigators

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

11 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

271

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

257-263

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Effect of a prior authorization process on antiplatelet therapy and outcomes in patients prescribed clopidogrel following coronary stenting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Restrictive access to clopidogrel and mortality following coronary stent implantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

The effect of CYP2C19 polymorphism on the pharmacokinetics and pharmacodynamics of clopidogrel: a possible mechanism for clopidogrel resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Cytochrome p-450 polymorphisms and response to clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Genetic determinants of response to clopidogrel and cardiovascular events

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Acid suppressive therapy use on an inpatient internal medicine service

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

CYP2C19 genotype and the PPIs--focus on rabeprazole

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Clopidogrel with or without omeprazole in coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2796.2011.02423.X

21 January 2018

Identifiers

10.1111/J.1365-2796.2011.02423.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43565621&oldid=2101136713"